Quick Answer: GLP-1 medications do not directly cause increased thirst, but some patients experience it as an indirect consequence of gastrointestinal side effects like vomiting or diarrhea that lead to dehydration
Kentuckians may recognize the following brand names of GLP-1 weight loss drugs: Ozempic (semaglutide from Novo Nordisk) Rybelsus (semaglutide from Novo Nordisk) Wegovy (semaglutide from Novo Nordisk) Mounjaro (tirzepatide from Eli Lilly and Company) Zepbound (tirzepatide from Eli Lilly and Company) Saxenda (liraglutide from Novo Nordisk) Victoza (liraglutide from Novo Nordisk) Trulicity (dulaglutide from Eli Lilly and Company) Bursor & Fisher, P.A
Brand-name medications, such as Ozempic, Wegovy, Zepbound and Mounjaro, can cost $1,000 or more per month
Femminella GD, Edison P
The alternative many people prefer is taking drops immediately upon waking, doing their morning routine during the hold and fasting period, then enjoying coffee after the 30-minute window
Clinical trials (SURPASS and SURMOUNT programmes) have shown that dual agonists may offer improved glycaemic control and weight reduction compared to GLP-1 monotherapy